CERo Therapeutics Holdings, Inc. CERO
$0.01
$0.004.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.03M | -5.89M | -4.54M | -4.86M | -5.42M |
| Total Depreciation and Amortization | 278.70K | 276.10K | 276.10K | 272.80K | 267.70K |
| Total Amortization of Deferred Charges | 609.90K | 136.80K | 105.40K | 500.00K | -- |
| Total Other Non-Cash Items | -2.38M | 2.49M | 259.70K | 347.90K | 890.60K |
| Change in Net Operating Assets | 196.90K | 217.40K | 93.00K | 530.60K | -364.00K |
| Cash from Operations | -2.33M | -2.76M | -3.81M | -3.21M | -4.62M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 500.00K | -- |
| Cash from Investing | -- | -- | 0.00 | 500.00K | -- |
| Total Debt Issued | 2.16M | 1.50M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 244.30K | 456.20K | 1.45M | -- | 2.72M |
| Repurchase of Common Stock | -- | -- | -- | -962.00K | -- |
| Issuance of Preferred Stock | -- | -- | 2.70M | 2.56M | 0.00 |
| Repurchase of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -700.20K | -174.50K | 0.00 |
| Cash from Financing | 2.41M | 1.96M | 3.45M | 1.42M | 2.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.00K | -804.90K | -359.70K | -1.28M | -1.90M |